Answer
Combining inotuzumab ozogamicin with medicines known to prolong the QT interval or induce Torsades de Pointes should be carefully considered, and the QT interval should be monitored when such medicines are combined.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 11Document updated
Sources checked